Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Muscarinic acetylcholine receptor M3 | ||
Ligand | BDBM50522815 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1888526 (CHEMBL4390203) | ||
Ki | 2.8±n/a nM | ||
Citation | Yamashita, Y; Tanaka, KI; Yamakawa, N; Asano, T; Kanda, Y; Takafuji, A; Kawahara, M; Takenaga, M; Fukunishi, Y; Mizushima, T Chemical modification-mediated optimisation of bronchodilatory activity of mepenzolate, a muscarinic receptor antagonist with anti-inflammatory activity. Bioorg Med Chem27:3339-3346 (2019) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Muscarinic acetylcholine receptor M3 | |||
Name: | Muscarinic acetylcholine receptor M3 | ||
Synonyms: | ACM3_HUMAN | CHRM3 | Cholinergic, muscarinic M3 | Muscarinic Receptors M3 | Muscarinic receptor M3 | RecName: Full=Muscarinic acetylcholine receptor M3 | ||
Type: | Enzyme | ||
Mol. Mass.: | 66151.03 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P20309 | ||
Residue: | 590 | ||
Sequence: |
| ||
BDBM50522815 | |||
n/a | |||
Name | BDBM50522815 | ||
Synonyms: | CHEMBL4442329 | ||
Type | Small organic molecule | ||
Emp. Form. | C29H32BrNO4 | ||
Mol. Mass. | 538.473 | ||
SMILES | [Br-].OC(C(=O)OC1C[N+]2(CCOc3ccccc3)CCC1CC2)(c1ccccc1)c1ccccc1 |(36.03,-18.83,;26.43,-20.78,;27.77,-21.55,;29.1,-22.32,;29.11,-23.86,;30.44,-21.54,;31.77,-22.31,;33.1,-21.53,;34.43,-22.31,;35.76,-21.54,;37.09,-22.31,;38.43,-21.55,;39.76,-22.32,;39.75,-23.86,;41.09,-24.63,;42.42,-23.86,;42.42,-22.32,;41.09,-21.55,;34.43,-23.85,;33.1,-24.61,;31.77,-23.85,;33.27,-23.65,;32.92,-22.6,;27.76,-20.01,;29.09,-19.24,;29.09,-17.7,;27.75,-16.93,;26.42,-17.71,;26.43,-19.25,;26.43,-22.33,;25.1,-21.55,;23.77,-22.33,;23.77,-23.87,;25.12,-24.63,;26.44,-23.86,)| | ||
Structure |